With chronic kidney disease projected to be the fifth leading cause of death by 2040, Nephrologist Dr. Adrian Sawyer is ...

Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension, chronic kidney disease (CKD), obstructive sleep apnea ...

HALF a million Brits with deadly high blood pressure could be cured by a transformative new treatment. Doctors from the UK ...

Addison’s disease is a rare condition in which the adrenal glands do not produce enough of the hormones cortisol and ...

A Radnor biopharma firm saw its stock price skyrocket after the company posted positive late-stage clinical trial results for ...

BofA Securities, Evercore ISI, Goldman Sachs & Co. LLC, Stifel and Wells Fargo Securities are acting as joint book-running managers for the offering. LifeSci Capital is acting as lead manager and H.C.

The hormonal axis involved in this process includes angiotensin, aldosterone ... Another early sign of kidney disease is Proteinuria, marked by significant albumin loss through the kidneys.

"With such severe ischemic heart disease, the risk of sudden ... by a dysfunctional RAAS [renin-angiotensin-aldosterone system] in the pig kidney, may have increased the risk of cardiac ...

The Furoscix 80 mg/10 ml subcutaneous injection is intended for oedema in adult CKD patients, including those with nephrotic ...